# Effects of Phosphate Binding With Sevelamer in Stage 3 Chronic Kidney Disease

> **NCT00806481** · PHASE2 · COMPLETED · sponsor: **University Hospital Birmingham NHS Foundation Trust** · enrollment: 120 (actual)

## Conditions studied

- Kidney Failure, Chronic
- Cardiovascular Diseases

## Interventions

- **DRUG:** Sevelamer carbonate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00806481
- **Lead sponsor:** University Hospital Birmingham NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2011-11-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00806481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00806481, "Effects of Phosphate Binding With Sevelamer in Stage 3 Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00806481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*